These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14217713)

  • 41. A method for the determination of xanthine and hypoxanthine in biological fluids.
    Simmonds HA; Wilson JD
    Clin Chim Acta; 1967 Apr; 16(1):155-61. PubMed ID: 6036907
    [No Abstract]   [Full Text] [Related]  

  • 42. Changes in gastric mucosal content of adenosine, xanthine and hypoxanthine induced by restrained water immersion stress: antiulcer effects of tetraprenylacetone.
    Itoh Y; Suzuki K; Matsubara M; Takeyama N; Kitazawa Y; Tanaka T
    Digestion; 1991; 48(1):25-33. PubMed ID: 1868966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous measurement of allantoin, uric acid, xanthine and hypoxanthine in blood by high-performance liquid chromatography.
    Czauderna M; Kowalczyk J
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):89-98. PubMed ID: 9518182
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased concentration of hypoxanthine in human central cerebrospinal fluid after subarachnoid haemorrhage.
    von Holst H; Sollevi A
    Acta Neurochir (Wien); 1985; 77(1-2):52-9. PubMed ID: 4036678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excretion of hypoxanthine and xanthine in a genetic disease of purine metabolism.
    Sweetman L; Nyhan WL
    Nature; 1967 Aug; 215(5103):859-60. PubMed ID: 6049739
    [No Abstract]   [Full Text] [Related]  

  • 46. [Destruction of muscle tissue and purine compound metabolism in hereditary muscular dystrophy].
    Toguzov RT; Sitnikov VF; Prokudin VIu; Tikhonov IuV; Pimenov AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1646-9. PubMed ID: 3811726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid.
    Kuracka L; Kalnovicová T; Líska B; Turcáni P
    Clin Chem; 1996 May; 42(5):756-60. PubMed ID: 8653903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia.
    Kaneko K; Fujimori S; Itoh H; Nakayama Y; Oyama H; Kanbayashi T; Miyashita H; Akaoka I
    J Rheumatol; 1988 Feb; 15(2):325-30. PubMed ID: 3361540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of purine base excretion in regulation of purine pools.
    Sabina RL; Hanks AR; Magill JM; Magill CW
    Mol Gen Genet; 1979 May; 173(1):31-8. PubMed ID: 157418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxanthine, xanthine, urate and creatinine concentration gradients in cerebrospinal fluid.
    Niklasson F; Hetta J; Degrell I
    Ups J Med Sci; 1988; 93(3):225-32. PubMed ID: 3238822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolism of orally and intravenously administered purines in rats.
    Savaiano DA; Ho CY; Chu V; Clifford AJ
    J Nutr; 1980 Sep; 110(9):1793-804. PubMed ID: 7411237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metabolism of purine nucleotides in the central nervous system in patients with phosphoribosylpyrophosphate synthetase hyperactivity and neurosensory deafness].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Sebastián Melián J; García Neito V
    Neurologia; 1990 Jan; 5(1):14-7. PubMed ID: 2163266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An enzymatic spectrophotometric method for the determination of xanthine and hypoxanthine.
    Klinenberg JR; Goldfinger S; Bradley KH; Seegmiller JE
    Clin Chem; 1967 Oct; 13(10):834-46. PubMed ID: 6073570
    [No Abstract]   [Full Text] [Related]  

  • 55. Identification of xanthine and hypoxanthine as components of assembly pheromone in excreta of argasid ticks.
    Dusbábek F; Simek P; Jegorov A; Tríska J
    Exp Appl Acarol; 1991 Aug; 11(4):307-16. PubMed ID: 1954803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clearance of oxypurines and uric acid in patients with gout].
    Vannoni D; Porcelli B; Di Stefano A; Pizzichini M; Leoncini R; Terzuoli L; Taddeo A; Marsini S; Morozzi G; Marcolongo R
    Medicina (Firenze); 1989; 9(3):297-9. PubMed ID: 2615606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. INHIBITION OF PRUINE PHOSPHORIBOSYLTRANSFERASES OF EHRLICH ASCITES-TUMOUR CELLS BY 6-MERCAPTOPURINE.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):64-70. PubMed ID: 14342250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxypurine excretion in normal newborn infants.
    Jensen MH; Jørgensen S
    Biol Neonate; 1977; 32(3-4):197-204. PubMed ID: 603805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus.
    Schmidt H; Siems WG; Grune T; Grauel EL
    J Perinat Med; 1995; 23(3):167-74. PubMed ID: 8568608
    [TBL] [Abstract][Full Text] [Related]  

  • 60. INHIBITION BY 6-MERCAPTOPURINE OF PURINE PHOSPHORIBOSYLTRANSFERASES FROM EHRLICH ASCITES-TUMOUR CELLS THAT ARE RESISTANT TO THE DRUG.
    ATKINSON MR; MURRAY AW
    Biochem J; 1965 Jan; 94(1):71-4. PubMed ID: 14342251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.